- Home
- VITL vs SDGR Comparison
VITL vs SDGR Comparison
Compare VITL & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VITL | SDGR |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | 2020 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VITL | SDGR |
|---|---|---|
| Price | $30.03 | $18.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | ★ $48.56 | $26.25 |
| AVG Volume (30 Days) | ★ 2.1M | 850.2K |
| Earning Date | 02-26-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.60 | N/A |
| EPS | ★ 1.32 | N/A |
| Revenue | ★ $711,881,000.00 | $256,951,000.00 |
| Revenue This Year | $28.26 | $23.69 |
| Revenue Next Year | $23.10 | $20.46 |
| P/E Ratio | $22.72 | ★ N/A |
| Revenue Growth | 23.56 | ★ 32.90 |
| 52 Week Low | $28.87 | $15.99 |
| 52 Week High | $53.13 | $28.47 |
Technical Indicators
Market Signals| Indicator | VITL | SDGR |
|---|---|---|
| Relative Strength Index (RSI) | 40.41 | 56.68 |
| Support Level | $29.27 | $17.50 |
| Resistance Level | $33.42 | $19.58 |
| Average True Range (ATR) | 1.24 | 0.70 |
| MACD | -0.23 | 0.10 |
| Stochastic Oscillator | 21.44 | 68.95 |
Price Performance
Historical ComparisonAbout VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.